Predictive Oncology Reports First Quarter 2023 Financial Results and Provides Business Update
15 mai 2023 17h15 HE
|
Predictive Oncology Inc.
EAGAN, Minn., May 15, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...
Predictive Oncology to Report First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 15, 2023
08 mai 2023 08h00 HE
|
Predictive Oncology Inc.
EAGAN, Minn., May 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...
Predictive Oncology Appoints Pharma, Biotech and Digital Health Veteran Veena Rao, PhD, MBA, to its Board of Directors
02 mai 2023 17h10 HE
|
Predictive Oncology Inc.
EAGAN, Minn., May 02, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...
Predictive Oncology Announces Reverse Stock Split
20 avr. 2023 17h10 HE
|
Predictive Oncology Inc.
Common Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023 EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the...
Predictive Oncology Adjourns Special Meeting of Stockholders
17 avr. 2023 18h00 HE
|
Predictive Oncology Inc.
MINNEAPOLIS, April 17, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...
Predictive Oncology Announces Appointment of Oncology Translational Research Leader Christoph Reinhard, Ph.D., MBA, to its Scientific Advisory Board
04 avr. 2023 08h30 HE
|
Predictive Oncology Inc.
EAGAN, Minn., April 04, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning...
Predictive Oncology Announces Collaboration with Integra Therapeutics to Advance Gene Therapy
30 mars 2023 08h30 HE
|
Predictive Oncology Inc.
EAGAN, Minn., March 30, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a science-driven company on the leading edge of oncology drug discovery and development, today announces it is...
Predictive Oncology Reports Year End 2022 Financial Results and Provides Business Update
21 mars 2023 17h15 HE
|
Predictive Oncology Inc.
EAGAN, Minn., March 21, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning...
Predictive Oncology and Cancer Research Horizons have partnered to pursue development of cancer drugs
17 mars 2023 07h00 HE
|
Predictive Oncology Inc.
EAGAN, Minn., March 17, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) together with Cancer Research Horizons, the innovation engine at the core of the world’s largest private...
Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common Stock
16 mars 2023 17h15 HE
|
Predictive Oncology Inc.
EAGAN, Minn., March 16, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that its Board of Directors declared a dividend of...